Genialis is revolutionizing precision oncology with its RNA-based foundation model of cancer biology. Built on data from ~1 million globally diverse patients, the large molecular model (LMM) (colloquially called the “Supermodel”) yields next-generation biomarkers to help pharma succeed in drug development, avoid long and costly clinical trial failures, and win the race for First-in-Class and Best-in-Class drugs. We partner with pharma, biotechs, and diagnostic companies to ensure promising drugs become life saving medicines.
Please contact us at info@genialis.com